VIETRI, LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 2.187
EU - Europa 2.094
AS - Asia 1.256
SA - Sud America 240
AF - Africa 93
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.879
Nazione #
US - Stati Uniti d'America 2.130
RU - Federazione Russa 493
IT - Italia 481
SG - Singapore 400
GB - Regno Unito 315
CN - Cina 303
IE - Irlanda 247
BR - Brasile 209
VN - Vietnam 147
HK - Hong Kong 133
DE - Germania 127
SE - Svezia 114
FR - Francia 97
IN - India 60
FI - Finlandia 55
ZA - Sudafrica 55
UA - Ucraina 43
KR - Corea 38
IQ - Iraq 30
CA - Canada 29
ES - Italia 27
ID - Indonesia 24
JP - Giappone 24
NL - Olanda 20
BD - Bangladesh 18
MX - Messico 18
CZ - Repubblica Ceca 16
PL - Polonia 15
SA - Arabia Saudita 14
TR - Turchia 14
PK - Pakistan 13
EG - Egitto 12
BE - Belgio 10
AR - Argentina 8
AU - Australia 8
IR - Iran 8
AT - Austria 7
CI - Costa d'Avorio 7
BG - Bulgaria 6
EC - Ecuador 6
KE - Kenya 6
PY - Paraguay 5
AZ - Azerbaigian 4
CH - Svizzera 4
CM - Camerun 4
LT - Lituania 4
VE - Venezuela 4
CL - Cile 3
CO - Colombia 3
MA - Marocco 3
OM - Oman 3
PA - Panama 3
PT - Portogallo 3
DZ - Algeria 2
HR - Croazia 2
IL - Israele 2
JM - Giamaica 2
LV - Lettonia 2
PH - Filippine 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MM - Myanmar 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
YE - Yemen 1
Totale 5.879
Città #
Dallas 393
Southend 254
Dublin 243
Singapore 239
Ashburn 172
Moscow 160
Fairfield 147
Santa Clara 145
Chandler 130
Hong Kong 122
Beijing 105
San Jose 100
New York 63
Seattle 57
Siena 57
Wilmington 55
Woodbridge 55
Houston 54
Lastra a Signa 54
Milan 52
Johannesburg 50
Helsinki 42
Cambridge 41
Ho Chi Minh City 40
Los Angeles 39
Hefei 37
Munich 35
Princeton 34
Jacksonville 31
Lauterbourg 30
Hanoi 28
Ann Arbor 22
Council Bluffs 22
Seoul 22
São Paulo 21
Florence 20
Gavirate 18
Redondo Beach 18
Shanghai 18
Chicago 17
Rome 17
San Mateo 17
The Dalles 17
Tokyo 17
Fremont 16
Haiphong 16
Málaga 16
Nuremberg 16
Buffalo 15
Dearborn 15
Orem 15
Baghdad 12
Boardman 12
Brno 12
Warsaw 12
Frankfurt am Main 11
Hanover 11
Jeddah 11
Montreal 11
Comun Nuovo 10
Brooklyn 9
Chennai 9
Da Nang 9
Jakarta 9
London 9
Bengaluru 8
Brescia 8
Denver 8
Mexico City 8
Paris 8
Phoenix 8
San Diego 8
Abidjan 7
Boston 7
Manchester 7
Padova 7
Piscataway 7
Portsmouth 7
Rio de Janeiro 7
Stockholm 7
Toronto 7
Anagni 6
Belo Horizonte 6
Dhaka 6
Lappeenranta 6
Turku 6
Agliana 5
Brussels 5
Catanzaro 5
Curitiba 5
Düsseldorf 5
Istanbul 5
Jinan 5
Lucca 5
Mumbai 5
Poplar 5
Querétaro 5
Sydney 5
Washington 5
Wuhan 5
Totale 3.785
Nome #
Serum amyloid A: a new biomarker in Idiopathic Pulmonary Fibrosis 394
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 387
An explainable model of host genetic interactions linked to COVID-19 severity 365
Antithrombin III as predictive indicator of survival in IPF patients treated with Nintedanib: a preliminary study 279
The effect of cigarette smoking on bronchoalveolar lavage protein profiles from patients with different interstitial lung diseases 272
Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib 261
Serum amyloid A in patients with idiopathic pulmonary fibrosis 236
A real-life experience with ImmunoCAP ISAC: the advantages of a new diagnostic method 235
Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosis 233
BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases 224
Bronchoalveolar lavage and serum KL-6 concentrations in chronic hypersensitivity pneumonitis: correlations with radiological and immunological features 216
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena 211
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies 204
Serum amyloid A: A potential biomarker of lung disorders 201
Effects of rituximab therapy on B cell differentiation and depletion 188
Krebs von den Lungen-6 as biomarker for disease severity assessment in interstitial lung disease: a comprehensive review 176
Serum CD59: a novel biomarker of idiopathic pulmonary fibrosis? 171
Utility of serological biomarker' panels for diagnostic accuracy of interstitial lung diseases 163
The pathogenetic mechanisms of cough in idiopathic pulmonary fibrosis 157
Specificity of serum amyloid A as a biomarker of idiopathic pulmonary fibrosis 139
Serum Amyloid A in lung transplantation 134
Real-life experience of severe asthma patients on Dupilumab treatment in Pordenone’s Hospital. 126
Author reply 108
Correction to: BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases (Clinical and Experimental Medicine, (2020), 20, 2, (207-216), 10.1007/s10238-020-00608-5) 104
Lipid metabolism in interstitial lung diseases: serum amyloid A a new potential biomarker in idiopathic pulmonary fibrosis 80
Siero Amiloide A: nuovo potenziale biomarcatore di Fibrosi Polmonare Idiopatica. 67
Eterogeneità clinica e radiologica della sarcoidosi: case report di sarcoidosi sistemica con coinvolgimento osseo con aspetti di malignità. 55
A case report on expanding horizon of endobronchial ultrasound through esophagus 53
Role of EBUS-TBNA in interstitial lung diseases: a case report of lymphangitis carcinomatosa. 49
Valutazione prognostica della Siero Amiloide A in pazienti affetti da Fibrosi Polmonare Idiopatica. 47
Esperienza in real-life della terapia con Pirfenidone in pazienti affetti da IPF. 46
Valutazione prognostica della Siero Amiloide A in pazienti affetti da Fibrosi Polmonare Idiopatica. 45
SAA and lipid metabolism in IPF 44
Biomarkers of Response to Nintedanib in IPF 41
FINDING BAL EOSINOPHILIA IN DESQUAMATIVE INTERSTITIAL PNEUMONIA 41
Atipical radiological NSIP pattern in GLILD: a case report 40
The thin line between sarcoidosis and cancer: can we consider PET as an oncologic screening tool in radiologically stable and asymptomatic sarcoidosis? 38
Esperienza in real-life della terapia con Pirfenidone in pazienti affetti da IPF. 37
Sarcoidosis and Autoimmune Inflammatory Syndrome Induced by Adjuvants: a case report. 35
Chilotorace maligno: patogenesi e valore prognostico. 33
A challenging convergence of conditions in a patient with thalassemia major presenting with thymoma and lymphangioleiomyomatosis: a case report. 33
MYASTHENIA GRAVIS IN INTERSTITIAL LUNG DISEASE DUE TO RHEUMATOID ARTHRITIS: A RARE COMORBIDITY TO CONSIDER. 31
TH-2 INFLAMMATION: A COMMON PATHWAY BETWEEN UIP PATTERN PULMONARY FIBROSIS AND HYPEREOSINOPHILIC SYNDROME 21
Serum Amyloid A and Lipid Metabolism in Idiopathic Pulmonary Fibrosis: A New Target for Antifibrotic Therapy? 19
Totale 6.039
Categoria #
all - tutte 18.444
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.444


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202181 0 0 0 0 0 0 0 0 0 33 25 23
2021/2022325 20 52 35 26 8 5 14 11 12 47 33 62
2022/2023466 25 52 35 40 27 79 31 57 53 30 30 7
2023/2024589 21 22 63 10 17 142 152 28 4 14 18 98
2024/20251.116 99 50 115 55 132 45 42 50 89 58 123 258
2025/20262.650 219 369 294 361 569 112 282 126 120 198 0 0
Totale 6.039